← FDA DRUG APPROVALS

FDA NDA · NDA016931

R-GENE

arginine hydrochloride

Sponsor: PHARMACIA AND UPJOHN

APPLICATION
NDA016931
TYPE
NDA
ORIGINAL APPROVAL
1973-02-28
LATEST ACTION
2010-01-17
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

R-GENE 10 · ReferencePrescription
ARGININE HYDROCHLORIDE 10GM/100ML · INJECTABLE · INJECTION

Approval history

2010-01-17Labeling · Supplement 31 · standardLetterAP
2003-08-13Labeling · Supplement 28 · standardLabelAP
2000-04-11Manufacturing (CMC) · Supplement 27 · priorityAP
1995-03-15Labeling · Supplement 26 · standardAP
1993-03-17Manufacturing (CMC) · Supplement 25 · priorityAP
1991-10-09Manufacturing (CMC) · Supplement 24 · priorityAP
1990-02-28Labeling · Supplement 23AP
1989-10-24Manufacturing (CMC) · Supplement 22 · priorityAP
1986-03-05Labeling · Supplement 21AP
1985-07-29Labeling · Supplement 20AP
1985-02-19Labeling · Supplement 18AP
1984-05-09Manufacturing (CMC) · Supplement 19 · priorityAP
1982-01-11Manufacturing (CMC) · Supplement 17 · priorityAP
1980-06-30Labeling · Supplement 14AP
1975-10-01Manufacturing (CMC) · Supplement 6 · priorityAP
1975-08-25Manufacturing (CMC) · Supplement 5 · priorityAP
1973-02-28Type 5 - New Formulation or New Manufacturer · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →